Ledger.Open graph →

SEC Form D · filed November 7, 2022

Faraday Pharmaceuticals, Inc

Offering

$102.8M

Sold

$52.8M

Exemption

Rule 506(b)

Industry

Pharmaceuticals

Location

SEATTLE, WA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Steven Gillis · Seattle, WADirector Simon Tulloch · Seattle, WAExec Stephen Hill · Seattle, WAExec · Director Brian Blackman · Seattle, WAExec Mark Roth · Seattle, WADirector · Promoter Terrance Mcguire · Waltham, MADirector Lawrence Gozlan · Seattle, WADirector Parker Spann · St. Louis, MOExec David Richardson · George Town, Cayman IslandsExec · Director Andrew Hersant · George Town, Cayman IslandsDirector · Promoter Candace J. Woods · Newark, NJDirector D. J. Harder · Calgary, Alberta, CanadaDirector Adam G. Yader · Monterey, CAExec Patrick Rock · Seattle, WAExec Ronald Kierpa · Seattle, WAExec Derek Ohly · WALTHAM, MAExec Andreas Guldin · WALTHAM, MAExec Elizabeth Campbell · Long Island City, NYDirector Joseph Luceri · Long Island City, NYDirector · Promoter Scott Perricelli · Long Island City, NYExec · Director Robert Halmi · YONKERS, NYDirector Patrick Rock · Seattle, WAExec Terrance Mcguire · Bedford, MADirector Ronald Kierpa · Seattle, WAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗